Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells

Endocrinology

Volumn 147, Issue 6, 2006, Pages 3027-3039

  Mendez, Pablo ^a   Garcia Segura, Luis Miguel ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA CATENIN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; WORTMANNIN;

ARTICLE; GENE EXPRESSION; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BETA CATENIN; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; GLYCOGEN SYNTHASE KINASE 3; HUMANS; NEURONS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 33646791491     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1224     Document Type: Article

References (55)

1. McEwen BS, Alves SE 1999 Estrogen actions in the central nervous system. Endocr Rev 20:279-307
2. Beato M, Herrlich P, Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
3. Merchenthaler I, Lane MV, Numan S, Dellovade TL 2004 Distribution of estrogen receptor α and β in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses. J Comp Neurol 473:270-291
4. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
5. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
6. Flint AP, Sheldrick EL, Fisher PA 2002 Ligand-independent activation of steroid receptors. Dom Anim Endocrinol 23:13-24
7. Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A 1994 Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol 8:910-918
8. Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC, Winder AD, Reiter R, Wellstein A, Martin MB, Stoica A 2003 Effect of estradiol on estrogen receptor-α gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 22:7998-8011
9. Azcoitia I, Sierra A, Garcia-Segura LM 1999 Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signalling. J Neurosci Res 58:815-822
10. Cardona-Gomez GP, Trejo JL, Fernandez AM, Garcia-Segura LM 2000 Estrogen receptors and insulin-like growth factor-I receptors mediate estrogen-dependent synaptic plasticity. Neuroreport 11:1735-1738
11. Duenas M, Torres-Aleman I, Naftolin F, Garcia-Segura LM 1996 Interaction of insulin-like growth factor-I and estradiol signaling pathways on hypothalamic neuronal differentiation. Neuroscience 74:531-539
12. Perez-Martin M, Azcoitia I, Trejo JL, Sierra A, Garcia-Segura LM 2003 An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat. Eur J Neurosci 18:923-930
13. Quesada A, Etgen AM 2002 Functional interactions between estrogen and insulin-like growth factor-I in the regulation of α1B-adrenoceptors and female reproductive function. J Neurosci 22:2401-2408
14. Maggi A, Ciana P, Belcredito S, Vegeto E 2004 Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu Rev Physiol 66:291-313
15. Kadowaki T, Tobe K, Honda-Yamamoto R, Tamemoto H, Kaburagi Y, Momomura K, Ueki K, Takahashi Y, Yamauchi T, Akanuma Y, Yazaki Y 1996 Signal transduction mechanism of insulin and insulin-like growth factor-1. Endocr J 43(Suppl):S33-S41
16. Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H 2001 Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: a new model for anti-estrogen resistance. J Biol Chem 276:9817-9824
17. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
18. Font dM, Brown M 2000 AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol 20:5041-5047
19. Grimes CA, Jope RS 2001 The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog Neurobiol 65:391-426
20. Harwood AJ 2001 Regulation of GSK-3: a cellular multiprocessor. Cell 105:821-824
21. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR 2000 Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406:86-90
22. Dominguez I, Itoh K, Sokol SY 1995 Role of glycogen synthase kinase 3β as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc Natl Acad Sci USA 92:8498-8502
23. Moon RT, Bowerman B, Boutros M, Perrimon N 2002 The promise and perils of Wnt signaling through β-catenin. Science 296:1644-1646
24. Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Jackson TR 1994 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA 91:7415-7419
25. Kalebic T, Blakesley V, Slade C, Plasschaert S, Leroith D, Helman LJ 1998 Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-R. Int J Cancer 76:223-227
26. Kuppers E, Beyer C 1999 Expression of estrogen receptor-α and β mRNA in the developing and adult mouse striatum. Neurosci Lett 276:95-98
27. Sambrook J, Fritch EF, Maniatis T 1989 Molecular cloning. 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory
28. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2000 Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-α- selective agonists. J Med Chem 43:4934-4947
29. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230-4251
30. Pasapera Limon AM, Herrera-Munoz J, Gutierrez-Sagal R, Ulloa-Aguirre A 2003 The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17β-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene. Mol Cell Endocrinol 200:199-202
31. Chen G, Huang LD, Jiang YM, Manji HK 1999 The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72:1327-1330
32. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee CL, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC 2000 Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 7:793-803
33. Ryves WJ, Harwood AJ 2001 Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280:720-725
34. Bondy CA, Cheng CM 2004 Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 490:25-31
35. Zhou FQ, Zhou J, Dedhar S, Wu YH, Snider WD 2004 NGF-induced axon growth is mediated by localized inactivation of GSK-3β and functions of the microtubule plus end binding protein APC. Neuron 42:897-912
36. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789
37. Pap M, Cooper GM 1998 Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 273:19929-19932
38. Kozikowski AP, Sun H, Brognard J, Dennis PA 2003 Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt. J Am Chem Soc 125:1144-1145
39. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P 1996 Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 272:1023-1026
40. Feyt C, Kienlen-Campard P, Leroy K, N'Kuli F, Courtoy PJ, Brion JP, Octave JN 2005 Lithium chloride increases the production of amyloid-β peptide independently from its inhibition of glycogen synthase kinase 3. J Biol Chem 280:33220-33227
41. Orme MH, Giannini AL, Vivanco MD, Kypta RM 2003 Glycogen synthase kinase-3 and Axin function in a β-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells. Mol Cell Neurosci 24:673-686
42. Phiel CJ, Klein PS 2001 Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 41:789-813
43. Johannessen CU 2000 Mechanisms of action of valproate: a commentary. Neurochem Int 37:103-110
44. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS 2001 Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734-36741
45. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C 2000 Estrogen receptor α rapidly activates the IGF-1 receptor pathway. J Biol Chem 275:18447-18453
46. Shang Y, Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468
47. Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B 2004 Glycogen synthase kinase-3β activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology 145:2941-2949
48. Wang L, Lin HK, Hu YC, Xie S, Yang L, Chang C 2004 Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3β in prostate cells. J Biol Chem 279:32444-32452
49. Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A 2000 A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141:4503-4511
50. Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A 1996 Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells. Mol Endocrinol 10:499-507
51. Medunjanin S, Hermani A, De Servi B, Grisouard J, Rincke G, Mayer D 2005 Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor α and is involved in the regulation of receptor activity. J Biol Chem 280:33006-33014
52. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
53. Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T, Kato S 2004 Wnt/β-catenin and estrogen signaling converge in vivo. J Biol Chem 279:40255-40258
54. Cardona-Gomez P, Perez M, Avila J, Garcia-Segura LM, Wandosell F 2004 Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and β-catenin in the hippocampus. Mol Cell Neurosci 25:363-373
55. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695-707